Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health

Christina S. Thornton, Madeline Mellett, Julie Jarand, Leila Barss, Stephen K. Field, Dina A. Fisher
European Respiratory Review 2021 30: 200299; DOI: 10.1183/16000617.0299-2020
Christina S. Thornton
1Division of Respirology, University of Calgary, Calgary, Canada
2Dept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
5Joint first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: christina.thornton@albertahealthservices.ca
Madeline Mellett
2Dept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
5Joint first authors
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Jarand
1Division of Respirology, University of Calgary, Calgary, Canada
2Dept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
3TB Services, University of Calgary, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leila Barss
1Division of Respirology, University of Calgary, Calgary, Canada
2Dept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
3TB Services, University of Calgary, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen K. Field
1Division of Respirology, University of Calgary, Calgary, Canada
2Dept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
3TB Services, University of Calgary, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dina A. Fisher
1Division of Respirology, University of Calgary, Calgary, Canada
2Dept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada
3TB Services, University of Calgary, Calgary, Canada
4Dept of Community Health Sciences, University of Calgary, Calgary, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Interactions between nontuberculous mycobacteria (NTM), the microbiome and the host inflammatory response. Upon presentation to the host cell, NTM along with resident lung microbiota induce complex inflammatory interactions that propagate NTM infection and disease. Initial stimulation by the innate immune response is composed mainly of neutrophils, macrophages, dendritic and natural killer cells. Activation is mediated by recognition of mycobacterial and microbial pathogen-associated molecular patterns (PAMPs) through Toll-like receptors (TLRs) and Nod-like receptors (NLRs). Phagocytosis and pathogenesis ensues with stimulation of the cellular-mediated immune response (T-cells and B-cells) through complex cytokine interactions, primarily interferon-γ (IFN-γ), interleukin (IL)-2, IL-12 and tumour necrosis factor-α (TNF-α). Various other cytokine and chemoattract ligands have been implicated in pathogenesis as listed. The role of the microbiome within this inflammatory cascade is complex and intricate within all of the aforementioned pathways. Created with BioRender.com. CCL: chemokine (C-C motif) ligand; MIP: macrophage inflammatory protein.

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Potential mechanistic pathways between nontuberculous mycobacteria (NTM) and the host lung microbiome. The complex interplay between healthy state and dysbiosis is influenced by microbial factors (species present in the microbiome, presence of virulence genes and acquisition of genes by horizontal gene transfer) and host factors (innate and adaptive immune system, external pressure selection such as by antimicrobials). This dynamic ecological niche plays a critical role in the transition between acquisition to infection and finally infection of organisms, such as NTM. Created with BioRender.com.

Tables

  • Figures
  • TABLE 1

    American Thoracic Society/Infectious Diseases Society of America criteria for diagnosing NTM pulmonary disease [19]

    Clinical criteriaRespiratory or constitutional symptoms and appropriate exclusion of other diagnosis and:
    Radiological criteriaReticular, interstitial or nodular infiltrate or cavitation on chest radiography, or high-resolution computed tomography scan that shows multifocal bronchiectasis with multiple small nodules, and:
    Microbiological criteriaPositive cultures from at least one bronchial wash or lavage, or positive sputum from at least two separate expectorated sputum samples; or transbronchial or other lung biopsy with microbiological histopathological features (granulomatous inflammation or acid-fast bacilli) and positive culture for NTM, or biopsy showing microbacterial histopathological features and one sputum sample or bronchial washing/lavage that is culture-positive for NTM.

    NTM: nontuberculous mycobacteria.

    • TABLE 2

      Summary of current studies examining the lung microbiome in individuals with NTM disease#

      YearPatient typePatient characteristicsPatients nSample typePredominant taxa by OTU
      Yamasaki et al. [50]2015NTM-positive bronchiectasisStable, met ATS criteria for NTM disease¶ and without history of antimicrobial treatment.27BALPrevotella, Streptococcus, Pseudomonas, Neisseria, Fusobacterium, Propionibacterium, Veillonella, Haemophilus, Granulicatella, Curvibacter, Lactobacillus
      NTM-negative bronchiectasisAs above but did not meet ATS criteria for NTM disease.25BALHaemophilus, Staphylococcus, Pseudomonas, Streptococcus, Prevotella, Trabulsiella, Granulicatella, Neisseria, Fusobacterium, Propionibacterium
      Sulaiman et al. [49]2018NTM-positive bronchiectasisStable, non-HIV, non-CF bronchiectasis. Inclusion criteria included CT imaging abnormalities and symptoms consistent with bronchiectasis. Exclusion criteria included patients with recent antimicrobial or corticosteroid therapy in the last month and recent history of smoking in the last year. Met ATS criteria for NTM disease¶.61Oral wash and induced sputumActinomyces, Actinomycetaceae, Streptophyta, Cyanobacteria, Streptophyta, Bifidobacteriales, Bifidobacteriaceae, Bifidobacterium, Rhodobacterales, Rhodobacteraceae, Bacillus
      BAL+Mycobacterium, Ralstonia, Clavibacter, Oxalobacteraceae, Enterobacter, Comamonas, Hyphomonadaceae, Xenococcaceae, Paracoccus, Lactobacillales
      NTM-negative bronchiectasisAs above but did not meet ATS criteria for NTM disease.
      45Oral wash and induced sputumProteobacteria, Gammaproteobacteria, Pasteurellales, Pasteurellalaceae, Pseudomonadales, Pseudomonadaceae, Pseudomonas, Actinobacillus, Weeksellaceae, Comamonadaceae
      BAL+Porphyromonas, Mannheimia, Kaistobacter, Selenomonas, Dialister
      Philley et al. [51]2019NTM-positive and breast cancerStable, patients met ATS criteria for NTM disease¶.15Expectorated sputum ± sera-derived extracellular vesicles§Haemophilus, Streptococcus, Neisseria, Veilonella, Rothia, Fusobacterium, Leptotrichia, Prevotella, Bacteroides, Escherichia/Shigella, Streptococcus, Alistipes, Cloacibacterium, Faecalibacterium, Lachnoclostridium, Staphylococcus, Neisseria, Fusicatenibacter, Fusobacterium, Lachnospira, Tepidimonus
      NTM-negativeStable, healthy controls.
      5Expectorated sputumHaemophilus, Streptococcus, Neisseria, Veillonella, Rothia, Fusobacterium, Leptotrichia, Prevotella

      NTM: nontuberculous mycobacteria; OTU: operational taxonomic unit; ATS: American Thoracic Society; BAL: bronchoalveolar lavage; CF: cystic fibrosis; CT: computed tomography. #: the studies presented here focus on non-CF conditions; ¶: as defined by the ATS/Infectious Diseases Society of America 2007 criteria [4]; +: a subset of 20 patients underwent BAL sampling, with eight patients identified as NTM-positive and 12 as NTM-negative; §: sera-derived extracellular vesicles were examined in a subset of four patients from the NTM-breast cancer group.

      PreviousNext
      Back to top
      View this article with LENS
      Vol 30 Issue 160 Table of Contents
      European Respiratory Review: 30 (160)
      • Table of Contents
      • Index by author
      Email

      Thank you for your interest in spreading the word on European Respiratory Society .

      NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

      Enter multiple addresses on separate lines or separate them with commas.
      The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health
      (Your Name) has sent you a message from European Respiratory Society
      (Your Name) thought you would like to see the European Respiratory Society web site.
      CAPTCHA
      This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
      Print
      Citation Tools
      The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health
      Christina S. Thornton, Madeline Mellett, Julie Jarand, Leila Barss, Stephen K. Field, Dina A. Fisher
      European Respiratory Review Jun 2021, 30 (160) 200299; DOI: 10.1183/16000617.0299-2020

      Citation Manager Formats

      • BibTeX
      • Bookends
      • EasyBib
      • EndNote (tagged)
      • EndNote 8 (xml)
      • Medlars
      • Mendeley
      • Papers
      • RefWorks Tagged
      • Ref Manager
      • RIS
      • Zotero

      Share
      The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health
      Christina S. Thornton, Madeline Mellett, Julie Jarand, Leila Barss, Stephen K. Field, Dina A. Fisher
      European Respiratory Review Jun 2021, 30 (160) 200299; DOI: 10.1183/16000617.0299-2020
      Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
      Full Text (PDF)

      Jump To

      • Article
        • Abstract
        • Abstract
        • Introduction
        • Nontuberculous mycobacteria
        • The respiratory microbiome and the landscape of microbial players
        • The respiratory microbiome and NTM: who is involved?
        • Pathogenesis of the mycobacteriome
        • Effect of NTM antibiotic treatment on the microbiome
        • Future directions and challenges
        • Footnotes
        • References
      • Figures & Data
      • Info & Metrics
      • PDF

      Subjects

      • Respiratory infections and tuberculosis
      • Tweet Widget
      • Facebook Like
      • Google Plus One

      More in this TOC Section

      • The role of smoking on COVID-19 progression: a meta-analysis
      • PAP therapy for post-stroke sleep disordered breathing
      • Severe COVID-19 versus multisystem inflammatory syndrome
      Show more Reviews

      Related Articles

      Navigate

      • Home
      • Current issue
      • Archive

      About the ERR

      • Journal information
      • Editorial board
      • Press
      • Permissions and reprints
      • Advertising
      • Sponsorship

      The European Respiratory Society

      • Society home
      • myERS
      • Privacy policy
      • Accessibility

      ERS publications

      • European Respiratory Journal
      • ERJ Open Research
      • European Respiratory Review
      • Breathe
      • ERS books online
      • ERS Bookshop

      Help

      • Feedback

      For authors

      • Instructions for authors
      • Publication ethics and malpractice
      • Submit a manuscript

      For readers

      • Alerts
      • Subjects
      • RSS

      Subscriptions

      • Accessing the ERS publications

      Contact us

      European Respiratory Society
      442 Glossop Road
      Sheffield S10 2PX
      United Kingdom
      Tel: +44 114 2672860
      Email: journals@ersnet.org

      ISSN

      Print ISSN: 0905-9180
      Online ISSN: 1600-0617

      Copyright © 2023 by the European Respiratory Society